What Clinical Strategies Are Applied for Botulinum Toxin Injection in the Oromandibular Region?
Publikation: Bidrag til bog/antologi/rapport › Bidrag til bog/antologi › Forskning › fagfællebedømt
Standard
What Clinical Strategies Are Applied for Botulinum Toxin Injection in the Oromandibular Region? / Bakke, Merete; Dalager, Torben; Møller, Eigild.
Botulinum Toxin Therapy Manual for Dystonia and Spasticity. red. / R Rosales; D Dressler. Rijeka : InTechOpen, 2016. s. 79-95.Publikation: Bidrag til bog/antologi/rapport › Bidrag til bog/antologi › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - CHAP
T1 - What Clinical Strategies Are Applied for Botulinum Toxin Injection in the Oromandibular Region?
AU - Bakke, Merete
AU - Dalager, Torben
AU - Møller, Eigild
PY - 2016
Y1 - 2016
N2 - Botulinum neurotoxin (BoNT) inhibits the release of acetylcholine from cholinergic nerve terminals in muscles or salivary glands. With reduced activation, the muscle activity or secretion decreases. Indications for medical, non‐cosmetic use of BoNT in the orofacial area include among others oromandibular dystonia, painful masseter hypertrophy, Frey's syndrome, and severe drooling. The chapter covers anamnestic characteristics of these conditions as well as clinical, electromyographic (EMG) and laboratory findings, treatment methods with guided injections, and outcome from systematic treatment controls and follow‐up examinations.
AB - Botulinum neurotoxin (BoNT) inhibits the release of acetylcholine from cholinergic nerve terminals in muscles or salivary glands. With reduced activation, the muscle activity or secretion decreases. Indications for medical, non‐cosmetic use of BoNT in the orofacial area include among others oromandibular dystonia, painful masseter hypertrophy, Frey's syndrome, and severe drooling. The chapter covers anamnestic characteristics of these conditions as well as clinical, electromyographic (EMG) and laboratory findings, treatment methods with guided injections, and outcome from systematic treatment controls and follow‐up examinations.
U2 - 10.5772/64271
DO - 10.5772/64271
M3 - Book chapter
SN - 978-953-51-2852-6
SP - 79
EP - 95
BT - Botulinum Toxin Therapy Manual for Dystonia and Spasticity
A2 - Rosales, R
A2 - Dressler, D
PB - InTechOpen
CY - Rijeka
ER -
ID: 173415158